BOBBY CHELETTE: Open Payments
NPI 1417565615 · WEST MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$424 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $424
Food & beverage: $424
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $223 |
| ABBVIE INC. | 4 | $72 |
| Lundbeck LLC | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: FANAPT, VRAYLAR, REXULTI, INGREZZA, INVEGA SUSTENNA, CAPLYTA, COBENFY.
Industry payments across LA — which companies pay providers there.
